• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.使用埃索素尔夫治疗后呼吸窘迫综合征婴儿肺动脉压力的变化。
Arch Dis Child Fetal Neonatal Ed. 1995 May;72(3):F176-9. doi: 10.1136/fn.72.3.f176.
2
Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.三种不同类型表面活性剂治疗呼吸窘迫综合征急性期肺动脉压的变化
Pediatr Pulmonol. 1998 Mar;25(3):191-5. doi: 10.1002/(sici)1099-0496(199803)25:3<191::aid-ppul9>3.0.co;2-p.
3
Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.外源性表面活性剂给药后呼吸窘迫综合征机械通气早产儿的肺力学:两种表面活性剂制剂的比较
Pediatr Pulmonol. 1994 Nov;18(5):273-8. doi: 10.1002/ppul.1950180502.
4
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.一项关于合成表面活性剂与小牛肺表面活性剂提取物预防新生儿呼吸窘迫综合征的多中心随机双盲对照试验。
Pediatrics. 1997 Jul;100(1):39-50. doi: 10.1542/peds.100.1.39.
5
Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.外源性表面活性物质(Exosurf)和固尔苏(Survanta)表面活性剂对呼吸窘迫综合征早期临床病程及早产并发症的比较疗效
J Perinatol. 1997 Nov-Dec;17(6):455-60.
6
Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.人工合成与天然表面活性剂治疗早产儿呼吸窘迫综合征的对比试验:发展中国家的经验
Pediatr Pulmonol. 1999 May;27(5):312-7. doi: 10.1002/(sici)1099-0496(199905)27:5<312::aid-ppul3>3.0.co;2-n.
7
A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.一项多中心随机试验,比较合成表面活性剂与改良牛肺表面活性剂提取物治疗新生儿呼吸窘迫综合征。佛蒙特牛津新生儿网络。
Pediatrics. 1996 Jan;97(1):1-6.
8
A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.一项关于天然表面活性剂与合成表面活性剂治疗呼吸窘迫综合征的多中心随机、盲法对照试验。
J Pediatr. 1996 Mar;128(3):396-406. doi: 10.1016/s0022-3476(96)70291-3.
9
[Systemic and pulmonary hemodynamics in the course of substitute therapy with exosurf neonatal in newborn infants with respiratory distress syndrome].[外源性肺表面活性物质替代治疗新生儿呼吸窘迫综合征过程中的体循环和肺循环血流动力学]
Anesteziol Reanimatol. 1996 Nov-Dec(6):7-10.
10
Exosurf treatment investigational new drug phase: effect of an individualized third dose in infants with respiratory distress syndrome.外源性表面活性物质治疗研究性新药阶段:个体化第三剂对呼吸窘迫综合征婴儿的影响。
Pediatr Pulmonol. 1992 Sep;14(1):16-22. doi: 10.1002/ppul.1950140105.

引用本文的文献

1
Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome.表面活性剂给药对患有呼吸窘迫综合征的早产新生儿血流动力学变化的初步观察性研究。
Ital J Pediatr. 2014 Mar 5;40(1):26. doi: 10.1186/1824-7288-40-26.
2
Echocardiographic assessment of early circulatory status in preterm infants with suspected intrauterine infection.超声心动图评估疑似宫内感染早产儿的早期循环状态
Arch Dis Child Fetal Neonatal Ed. 2006 Mar;91(2):F105-10. doi: 10.1136/adc.2005.079079. Epub 2005 Oct 20.
3
A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.天然和合成外源性表面活性剂治疗新生儿呼吸窘迫综合征的风险效益评估
Drug Saf. 1998 May;18(5):321-37. doi: 10.2165/00002018-199818050-00002.
4
Pulmonary artery pressure: early predictor of chronic lung disease in preterm infants.肺动脉压:早产儿慢性肺病的早期预测指标
Arch Dis Child Fetal Neonatal Ed. 1998 Jan;78(1):F20-4. doi: 10.1136/fn.78.1.f20.
5
The effects of surfactant on haemodynamics in hyaline membrane disease.表面活性剂对透明膜病血流动力学的影响。
Arch Dis Child Fetal Neonatal Ed. 1997 Mar;76(2):F67-9. doi: 10.1136/fn.76.2.f67.
6
Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.使用埃索苏尔夫治疗后呼吸窘迫综合征婴儿的肺动脉压力变化
Arch Dis Child Fetal Neonatal Ed. 1996 Mar;74(2):F151. doi: 10.1136/fn.74.2.f151-a.
7
Indirect estimates of pulmonary artery pressure.肺动脉压力的间接估计值。
Arch Dis Child Fetal Neonatal Ed. 1996 Jan;74(1):F79. doi: 10.1136/fn.74.1.f79.

本文引用的文献

1
Pulmonary artery pressure changes in the very low birthweight infant developing chronic lung disease.极低出生体重儿患慢性肺病时的肺动脉压力变化
Arch Dis Child. 1993 Mar;68(3 Spec No):303-7. doi: 10.1136/adc.68.3_spec_no.303.
2
Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome.
J Pediatr. 1993 Jul;123(1):115-9. doi: 10.1016/s0022-3476(05)81553-7.
3
Doppler-derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome.急性新生儿呼吸窘迫综合征中经多普勒测量的收缩期肺动脉压
Pediatrics. 1994 May;93(5):769-73.
4
Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.新生儿的静态呼吸顺应性。III:外源性表面活性剂治疗后的早期变化。
Arch Dis Child Fetal Neonatal Ed. 1994 Jan;70(1):F19-24. doi: 10.1136/fn.70.1.f19.
5
Increased shunt through the patent ductus arteriosus after surfactant replacement therapy.表面活性剂替代疗法后动脉导管未闭导致的分流增加。
J Pediatr. 1982 Jan;100(1):101-7. doi: 10.1016/s0022-3476(82)80247-3.
6
Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.应用脉冲多普勒技术对肺动脉高压进行无创评估。
Circulation. 1983 Aug;68(2):302-9. doi: 10.1161/01.cir.68.2.302.
7
Doppler echocardiographic prediction of pulmonary arterial hypertension in congenital heart disease.先天性心脏病中肺动脉高压的多普勒超声心动图预测
Am J Cardiol. 1984 Apr 1;53(8):1110-5. doi: 10.1016/0002-9149(84)90646-5.
8
Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization.
Am J Cardiol. 1986 Apr 1;57(10):859-63. doi: 10.1016/0002-9149(86)90627-2.
9
Factors affecting use of the Doppler-determined time from flow onset to maximal pulmonary artery velocity for measurement of pulmonary artery pressure in children.影响使用多普勒测定的从血流起始至肺动脉最大流速时间来测量儿童肺动脉压力的因素。
Am J Cardiol. 1986 Aug 1;58(3):352-6. doi: 10.1016/0002-9149(86)90076-7.
10
Prediction of peak pulmonary artery pressure by continuous-wave Doppler echocardiography in infants and children.连续波多普勒超声心动图预测婴幼儿和儿童的肺动脉压峰值
Pediatr Cardiol. 1988;9(4):225-9. doi: 10.1007/BF02078413.

使用埃索素尔夫治疗后呼吸窘迫综合征婴儿肺动脉压力的变化。

Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.

作者信息

Hamdan A H, Shaw N J

机构信息

Regional Neonatal Intensive Care Unit, Liverpool Maternity Hospital.

出版信息

Arch Dis Child Fetal Neonatal Ed. 1995 May;72(3):F176-9. doi: 10.1136/fn.72.3.f176.

DOI:10.1136/fn.72.3.f176
PMID:7796233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2528443/
Abstract

The pulmonary artery pressure (PAP) changes were studied using Doppler echocardiography in preterm infants treated with an artificial surfactant (Exosurf) during the acute phase of respiratory distress syndrome (RDS). The ratio of pulmonary artery acceleration time to the right ventricular ejection time (AT:RVET), measured from the Doppler wave form, was determined in 38 infants before the first dose of Exosurf, at one and six hours after the first dose, immediately before the second dose of Exosurf, and at one, six, 12, 36, and 60 hours subsequently. The median AT:RVET ratio corrected for heart rate (AT:RVET(c)) increased significantly an hour after administration of the first dose of Exosurf from 0.330 (0.273-0.410) to 0.380 (0.303-0.445) and similarly an hour after the second dose from 0.426 (0.252-0.495) to 0.440 (0.373-0.500). These changes occurred against a steady increase in the median AT:RVET(c) over the first 72 hours. It is concluded that the reduction in PAP correlates well with clinical parameters of disease severity and raises questions regarding the mode of action of Exosurf.

摘要

在呼吸窘迫综合征(RDS)急性期,使用多普勒超声心动图研究了接受人工表面活性剂(Exosurf)治疗的早产儿的肺动脉压(PAP)变化。从多普勒波形测量的肺动脉加速时间与右心室射血时间之比(AT:RVET),在38例婴儿首次给予Exosurf之前、首次给药后1小时和6小时、即将给予第二次Exosurf之前以及随后的1、6、12、36和60小时测定。校正心率后的AT:RVET中位数比值(AT:RVET(c))在首次给予Exosurf后1小时显著增加,从0.330(0.273 - 0.410)增至0.380(0.303 - 0.445),第二次给药后1小时也类似地从0.426(0.252 - 0.495)增至0.440(0.373 - 0.500)。这些变化是在最初72小时内AT:RVET(c)中位数持续增加的背景下发生的。结论是PAP的降低与疾病严重程度的临床参数密切相关,并引发了关于Exosurf作用方式的问题。